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Tinnitus is a common phantom sensation resulting most often from sensory deprivation,
and for which little knowledge on the molecular mechanisms exists. While the existing
evidence for a genetic influence on the condition has been until now sparse and
underpowered, recent data suggest that specific forms of tinnitus have a strong genetic
component revealing that not all tinnitus percepts are alike, at least in how they are
genetically driven. These new findings pave the way for a better understanding on how
phantom sensations are molecularly driven and call for international biobanking efforts.
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PERSPECTIVE
For decades, tinnitus was considered a consequence of environmental factors, with low genetic
contribution. The numerous etiologies, such as aging (presbycusis), noise exposure, stress,
hypertension, diabetes, ototoxic medications, temporomandibular joint disorders, traumatic or
ischemic damage, vascular problems, middle-ear problems, and the complex pathophysiology
involving peripheral and central auditory and non-auditory structures, have led to the belief that
tinnitus is a consequence of some other disease.
The knowledge on the genetic basis of tinnitus was recently reviewed (Vona et al., 2017)
and phenotyping strategies have been proposed based on the assumption that tinnitus should be
considered as an ensemble of sub-entities called subtypes (Lopez-Escamez et al., 2016). A small
familial aggregation study (n= 198 families) found no obvious heritability (Hendrickx et al., 2007),
and the first large population-based family study (n = 52,045) made an estimate of heritability of
0.11 (Kvestad et al., 2010). But a recent twin study revealed a higher heritability of 0.4, indicating
that a larger fraction of the variance can be due to genetic variants than previously reported (Bogo
et al., 2016). Such discrepancies may originate from differences in the design and formulation
of the questionnaires, which have been found to vary greatly in prevalence studies on tinnitus
(McCormack et al., 2016).
The tinnitus phenotype could also be grounds for diverging heritability values, but
what defines a tinnitus phenotype is highly debated. We indeed consider that a more
precise definition of a homogeneous phenotype will be essential in the design of genetic
studies. A larger twin study performed by members of the TINNET1 consortium recently
1http://tinnet.tinnitusresearch.net/
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considered the laterality of tinnitus as a potential genetic subtype
(Maas et al., 2017). A key finding was that bilateral tinnitus
had higher heritability than unilateral tinnitus. The study was
based on self-reported data from the Swedish Twin Registry, one
of the largest twin registries in the world (Lichtenstein et al.,
2002, 2006; Pedersen et al., 2002; van Dongen et al., 2012).
Of a total of 70,186 twins that answered questions related to
tinnitus, 15% of them experienced tinnitus. 10,464 concordant
or discordant pairs for tinnitus were identified, in which 6,990
subjects had tinnitus. When considering tinnitus as a whole,
a moderate genetic contribution (near 40%) was found (Bogo
et al., 2016). However, when twins were stratified – based on
tinnitus experienced in one ear (unilateral) or in both ears
(bilateral) as well as on gender – bilateral tinnitus reached a
heritability of 0.68 in men (Maas et al., 2017). Such values
are close to the levels of heritability for schizophrenia and
attention deficit hyperactive disorder (ADHD), two well known
heritable conditions (Table 1). Although more work is required
for establishing the contribution of hearing loss in such high
heritability values (e.g., by including exhaustive auditory data),
these findings open the possibility of specific forms of tinnitus
being more genetically driven than others and pave the way
for future genetic studies considering subtypes. These findings,
however, need to be replicated in other twin cohorts as well as
familial studies.
In line with genetic association studies of other complex
traits, published studies to find genetic markers for chronic
tinnitus patients in candidate genes have been underpowered
(n = 95–288) and failed to identify robustly associated genetic
variants (Sand et al., 2010, 2011, 2012a,b; Gallant et al.,
2013). In spite of a lowly powered tinnitus group (N = 167)
and no significant associations found, a recent genome-wide
association study (GWAS) identified some pathways (e.g.,
TABLE 1 | Classification of tinnitus heritability against other disorders.
Trait Heritability Number of Twin pairs
Diabetes, type 1 0.88 22 650
Schizophrenia 0.81 Meta-analysis
ADHD 0.76 Review
Autism 0.71 11 535
Bilateral tinnitus (men) 0.68 10 464
Diabetes, type 2 0.64 13 888
Coronary heart disease 0.57 10 483
Alzheimer’s disease 0.48 662
Any tinnitus 0.43 10 464
Prostate cancer 0.42 21 000
Systolic blood pressure 0.42 1 617
Bilateral tinnitus (women) 0.41 10 464
Colorectal cancer 0.35 44 788
Parkinson’s disease 0.34 46 436
Breast cancer 0.27 23 788
Unilateral tinnitus 0.27 10 464
MS 0.25 Review
Modified from van Dongen et al. (2012) with permission from the Nature Publishing
Group. Tinnitus values are marked in red.
oxidative stress, endoplasmatic reticulum stress, and serotonin
reception mediated signaling) potentially involved in tinnitus
(Gilles et al., 2017). Supporting the need of better characterizing
the tinnitus cases, Pawelczyk and colleagues investigated 99
single nucleotide polymorphisms targeting 10 genes involved in
the potassium recycling pathway in the inner ear (128 tinnitus
cases and 498 controls both exposed to occupational noise)
(Pawelczyk et al., 2012). However, two of the identified SNPs
were not subjected to multiple testing and were thus considered
nominally significant. An important lesson from GWAS on
other complex traits, such as schizophrenia and major depressive
disorder (Sullivan et al., in press), is that far larger sample sizes
are needed in order to identify genome-wide significant genetic
variants. Therefore, an important next step in the search for
genetic variants associated with tinnitus will be to perform joint
GWAS analysis of thousands of tinnitus patients and healthy
controls.
Since familial tinnitus is a rare condition, the selection of
multiplex tinnitus families, in addition to unrelated cases and
controls, for exome sequencing, is another potential strategy
to be used for the discovery of genes involved in tinnitus.
This strategy has been successful in the identification of DTNA,
PRKCB, SEMA3D and DPT in autosomal dominant Meniere
disease (Requena et al., 2015; Martin-Sierra et al., 2016, 2017).
With tinnitus being a condition with highly unmet clinical
needs (Cederroth et al., 2013), the recent identification of a high
heritability opens door to exciting research. Since it is more than
likely that tinnitus is a polygenic trait and it will require the
study of several thousand samples, audiologists and ENT doctors
should optimize their phenotyping strategies for instance by
using high frequency audiometry and multivariate questionnaire
data (Muller et al., 2016; Schlee et al., 2017), initiate incentives
to allocate a specific ICD-code for bilateral tinnitus, and start
biobanking samples (Lopez-Escamez et al., 2016). Regarding the
latter, since it is not custom for an ENT clinic to collect samples
for DNA biobanking, guidelines should emerge to promote good
practice (Fuller et al., 2017) and enable the creation of a large
consortium to join efforts to decipher the genetic basis of tinnitus.
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